Tarsus Pharmaceuticals TARS
NASDAQ TARS
$72.08 +1.58 (+2.24%)
At close: Oct 22, 2026 · 4:00 PM EDT

Tarsus Pharmaceuticals (TARS) Long-Term Debt Issuances (2019 - 2024)

Updated

Tarsus Pharmaceuticals (TARS) recorded Long-Term Debt Issuances of $75 million in FY2024, up 650.0% from $10 million in FY2023.

Analysis

Tarsus Pharmaceuticals (TARS) Long-Term Debt Issuances (2019 - 2024) Analysis & Trends

Starting with FY2019, Tarsus Pharmaceuticals' Long-Term Debt Issuances history includes 4 years.

  • Annual Long-Term Debt Issuances has a five-year compound annual growth rate of 106.7% (FY2019 to FY2024).
  • Per Business Quant data, TARS's Long-Term Debt Issuances was $10 million in FY2023 (-50.0%) and $20 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Tarsus Pharmaceuticals 3.14 Bn 2.09 Bn 161.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 75.00 Mn
Sep 30, 2023 5.00 Mn
Mar 31, 2023 5.00 Mn
Mar 31, 2022 20.00 Mn
Dec 31, 2019 989,000.00
API Access

Tarsus Pharmaceuticals Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=TARS&period=max&api_key=YOUR_API_KEY